DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Enanta Pharmaceuticals, Inc. (ENTA)
« Back to company indexENTA Chatter Timeline
Stock Ticker for ENTA
Most Active Tweeters for ENTA
| User | Tweets |
|---|---|
| @Tickeron | 10 |
| @Gambiste1 | 3 |
| @dakotafinancial | 3 |
| @DewDiligence | 2 |
| @dispatchtribune | 2 |
Recent Tweets for ENTA
 |
@Gambiste1 RT @Tickeron: $ENTA's price moved above its 50-day Moving Average on November 25, 2019. View odds for this and other indicators: https://t.… December 7th 2019, 8:12pm |
 |
@Tickeron $ENTA's price moved above its 50-day Moving Average on November 25, 2019. View odds for this and other indicators:… https://t.co/Hn8vcEPOrG December 7th 2019, 8:12pm |
 |
@dakotafinancial Enanta Pharmaceuticals $ENTA Lifted to “Sell” at BidaskClub https://t.co/keL0CpOSKh December 7th 2019, 2:12pm |
|
@Tickeron $ENTA's price moved above its 50-day Moving Average on November 25, 2019. View odds for this and other indicators:… https://t.co/re7W7R0D0y December 6th 2019, 9:12pm |
 |
@dispatchtribune Analysts Anticipate Enanta Pharmaceuticals Inc $ENTA Will Post Earnings of $0.63 Per Share https://t.co/cMw2MjbIMH December 6th 2019, 6:12am |
 |
@EnterpriseLeade Zacks: Brokerages Expect Enanta Pharmaceuticals Inc $ENTA to Announce $0.63 Earnings Per Share https://t.co/xTz8hXRvGu December 6th 2019, 6:12am |
 |
@AmericanBanking Zacks: Brokerages Expect Enanta Pharmaceuticals Inc $ENTA to Announce $0.63 Earnings Per Share https://t.co/jUqviSocdn #stocks December 6th 2019, 6:12am |
 |
@dailypoliticaln Enanta Pharmaceuticals $ENTA Upgraded at BidaskClub https://t.co/9ral56Warg December 6th 2019, 6:12am |
 |
@TickerReport BidaskClub Upgrades Enanta Pharmaceuticals $ENTA to “Sell” https://t.co/eqgz2pFkEi December 6th 2019, 6:12am |
|
@Tickeron $ENTA's price moved above its 50-day Moving Average on November 25, 2019. View odds for this and other indicators:… https://t.co/QSiwQ6GuRw December 5th 2019, 8:12pm |
|
@dakotafinancial Enanta Pharmaceuticals Inc $ENTA Receives Consensus Recommendation of “Hold” from Brokerages https://t.co/acWdRZV2yj December 3rd 2019, 10:12am |
|
@AmericanBanking Enanta Pharmaceuticals Inc $ENTA Receives Consensus Recommendation of “Hold” from Brokerages https://t.co/n3FsNf2evB #stocks December 3rd 2019, 10:12am |
 |
@tradersreport RT @Tickeron: $ENTA in +1.76% Uptrend, growing for three consecutive days on November 29, 2019. View odds for this and other indicators: ht… December 2nd 2019, 7:12pm |
|
@Tickeron $ENTA in +1.76% Uptrend, growing for three consecutive days on November 29, 2019. View odds for this and other indi… https://t.co/x222lADIsq December 2nd 2019, 7:12pm |
|
@tradersreport RT @Tickeron: $ENTA in +1.76% Uptrend, advancing for three consecutive days on November 29, 2019. View odds for this and other indicators:… December 1st 2019, 11:12pm |
|
@Tickeron $ENTA in +1.76% Uptrend, advancing for three consecutive days on November 29, 2019. View odds for this and other in… https://t.co/qVca6EWuzY December 1st 2019, 11:12pm |
|
@Tickeron $ENTA in +1.76% Uptrend, advancing for three consecutive days on November 29, 2019. View odds for this and other in… https://t.co/8AsAwes9h3 December 1st 2019, 12:12am |
|
@Tickeron $ENTA's 10-day Moving Average crossed above its 50-day Moving Average on November 26, 2019. View odds for this and… https://t.co/bB8AR2WRs1 November 29th 2019, 7:11pm |
|
@Tickeron $ENTA's 10-day Moving Average broke above its 50-day Moving Average on November 26, 2019. View odds for this and ot… https://t.co/Aj9NpTYKuW November 28th 2019, 5:11pm |
|
@Tickeron $ENTA's 10-day Moving Average crossed above its 50-day Moving Average on November 26, 2019. View odds for this and… https://t.co/OT9jUo2eMd November 27th 2019, 7:11pm |
 |
@Stock_News_Now $ENTA: New SEC Filing for ENTA: Form 10-K (No. 0001564590-19-044729): https://t.co/6EKtGPYIJs November 27th 2019, 4:11pm |
 |
@investor_feed $ENTA 10-K Enanta Pharmaceuticals (27 Nov, 4:06pm) ? 2019 FY Earnings https://t.co/wfHQr5HAzP #ENTA #10K… https://t.co/yDqpyaGiIn November 27th 2019, 4:11pm |
|
@Tickeron $ENTA's price moved above its 50-day Moving Average on November 25, 2019. View odds for this and other indicators:… https://t.co/p4zEXQWmCp November 27th 2019, 12:11am |
 |
@SwingTradeBot Rose Above Upper Bollinger Band today: $ENTA ... https://t.co/AyIukUGmib November 26th 2019, 2:11pm |
 |
@BlueBioNow $ENTA considerable price movement 3.07 % change recently https://t.co/Lw9D5c1Gqa November 26th 2019, 5:11am |
|
@dakotafinancial Enanta Pharmaceuticals $ENTA Downgraded by Zacks Investment Research https://t.co/wtkQScxOI4 November 26th 2019, 3:11am |
 |
@TheMarketsDaily Enanta Pharmaceuticals $ENTA Downgraded by Zacks Investment Research https://t.co/ItNViPDLSZ November 26th 2019, 3:11am |
 |
@ZolmaxNews JMP Securities Downgrades Enanta Pharmaceuticals $ENTA to Market Perform https://t.co/stmvo2yoII November 26th 2019, 1:11am |
 |
@DewDiligence RT @DewDiligence: @bio_clouseau $ENTA insiders are bullish too (new exercise-and-hold transaction reported today): https://t.co/68Vdmw6NCc November 25th 2019, 5:11pm |
|
@DewDiligence @bio_clouseau $ENTA insiders are bullish too (new exercise-and-hold transaction reported today): https://t.co/68Vdmw6NCc November 25th 2019, 5:11pm |
 |
@InsiderAlertsIA $ENTA: New Insider Filing on Sr. VP & General Counsel NATHANIEL S. GARDINER: https://t.co/dOD5Of5BGz November 25th 2019, 5:11pm |
|
@BlueBioNow $ENTA substantial stock price changes -4.36 % change recently https://t.co/Lw9D5c1Gqa November 25th 2019, 12:11pm |
|
@Gambiste1 RT @newsfilterio: Enanta Pharmaceuticals (NASDAQ:ENTA) Downgraded by Zacks Investment Research $ENTA https://t.co/NFuKXG61nd November 25th 2019, 6:11am |
 |
@stocknewstimes Enanta Pharmaceuticals $ENTA Downgraded by Zacks Investment Research https://t.co/r6XuDkex9w November 25th 2019, 5:11am |
 |
@newsfilterio Enanta Pharmaceuticals (NASDAQ:ENTA) Downgraded by Zacks Investment Research $ENTA https://t.co/NFuKXG61nd November 25th 2019, 5:11am |
|
@dispatchtribune Zacks Investment Research Downgrades Enanta Pharmaceuticals $ENTA to Sell https://t.co/AyGhapo8fv November 25th 2019, 5:11am |
 |
@ThisLincolnian Enanta Pharmaceuticals $ENTA Lowered to Market Perform at JMP Securities https://t.co/EGrOurTziK November 25th 2019, 4:11am |
 |
@AdamB1438 Anybody follow $ENTA? This was a home run for me a couple of years ago, but haven't kept up for a couple of years. November 24th 2019, 11:11am |
 |
@WeekHerald Enanta Pharmaceuticals $ENTA Stock Rating Lowered by Zacks Investment Research https://t.co/kAfyKniEo3 November 24th 2019, 4:11am |
 |
@OlympiaReport Enanta Pharmaceuticals $ENTA Stock Rating Lowered by Zacks Investment Research https://t.co/QLIKX9DvVA November 24th 2019, 4:11am |
|
@dailypoliticaln Enanta Pharmaceuticals $ENTA Rating Lowered to Market Perform at JMP Securities https://t.co/pWyMRLAlXs November 24th 2019, 1:11am |
|
@TickerReport Enanta Pharmaceuticals $ENTA Rating Lowered to Market Perform at JMP Securities https://t.co/rtgN0JdRnR November 24th 2019, 1:11am |
|
@Gambiste1 RT @gcassidy718: $ENTA good earnings are hopefully coming next quarter -4.36 % change recently https://t.co/C3ytdcXv8r November 24th 2019, 12:11am |
 |
@gcassidy718 $ENTA good earnings are hopefully coming next quarter -4.36 % change recently https://t.co/C3ytdcXv8r November 23rd 2019, 10:11pm |
|
@stocknewstimes Enanta Pharmaceuticals $ENTA Downgraded by JMP Securities https://t.co/SNoqBD3ABx November 23rd 2019, 2:11pm |
|
@TheMarketsDaily Enanta Pharmaceuticals $ENTA Downgraded to Market Perform at JMP Securities https://t.co/IpxvGWaaNL November 23rd 2019, 2:11pm |
|
@EnterpriseLeade Enanta Pharmaceuticals $ENTA Cut to Sell at Zacks Investment Research https://t.co/QedzwtnNLr November 23rd 2019, 12:11pm |
 |
@TranscriptDaily Enanta Pharmaceuticals $ENTA Downgraded by Zacks Investment Research to Sell https://t.co/9cMz8OHycW November 23rd 2019, 12:11pm |
|
@TheMarketsDaily Enanta Pharmaceuticals $ENTA Releases Quarterly Earnings Results, Misses Expectations By $0.12 EPS https://t.co/ustLmsk6kM November 23rd 2019, 8:11am |
|
@ZolmaxNews Enanta Pharmaceuticals $ENTA Downgraded by Zacks Investment Research https://t.co/FUgxorDnM5 November 22nd 2019, 10:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.